IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway

Figure 3

IPO5 enrichment analysis diagram based on GSEA. GSEA presented both group’s expression was mainly enriched in (a) basic transcription factors, (b) cell cycle, (c) RNA degradation, (d) small cell lung cancer, (e) oxidative phosphorylation, (f) Parkinson’s disease, (g) phenylalanine metabolism, and (h) arachidonic acid metabolism, in 8 pathways. NES: normalized enrichment score; ES: concentration score; FDR: error detection rate.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)